0001567619-20-006578.txt : 20200317 0001567619-20-006578.hdr.sgml : 20200317 20200317162451 ACCESSION NUMBER: 0001567619-20-006578 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200317 DATE AS OF CHANGE: 20200317 EFFECTIVENESS DATE: 20200317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gracili Therapeutics, Inc. CENTRAL INDEX KEY: 0001806319 IRS NUMBER: 833445958 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-363080 FILM NUMBER: 20721313 BUSINESS ADDRESS: STREET 1: 15 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 919-549-8854 MAIL ADDRESS: STREET 1: 15 TW ALEXANDER DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001806319 Gracili Therapeutics, Inc. 15 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 919-549-8854 DELAWARE None None Corporation true 2019 John Taylor 15 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Atul Chopra 15 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Executive Officer Director Andy Jordan 15 TW Alexander Drive Research Triangle Park NC NORTH CAROLINA 27709 Director Pharmaceuticals Decline to Disclose 06b false 2020-03-09 false true false 0 Indefinite 100000 Indefinite false 1 0 0 0 false Gracili Therapeutics, Inc. /s/ John Taylor John Taylor Chief Executive Officer 2020-03-17